Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial

Al Kaabi, N; Zhang, YT; Xia, SL; Yang, YK; Al Qahtani, MM; Abdulrazzaq, N; Al Nusair, M; Hassany, M; Jawad, JS; Abdalla, J; Hussein, SE; Al Mazrouei, SK; Al Karam, M; Li, XG; Yang, XQ; Wang, W; Lai, BA; Chen, W; Huang, SH; Wang, Q; Yang, T; Liu, Y; Ma, R; Hussain, ZM; Khan, T; Fasihuddin, MS; You, WY; Xie, ZQ; Zhao, YX; Jiang, ZW; Zhao, GQ; Zhang, YB; Mahmoud, S; ElTantawy, I; Xiao, P; Koshy, A; Zaher, WA; Wang, H; Duan, K; Pan, A; Yang, XM

Yang, XM (corresponding author), China Natl Biotec Grp Co Ltd, B2 Shuangqiao Rd, Beijing, Peoples R China.; Pan, A (corresponding author), Huazhong Univ Sci & Technol, Sch Publ Hlth, Tongji Med Coll, 13 Hangkong Rd, Wuhan, Peoples R China.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021; 326 (1): 35

Abstract

This interim analysis of an ongoing randomized trial evaluates the efficacy of 2 inactivated coronavirus vaccines for preventing symptomatic COVID-19 ......

Full Text Link